NMLSF (Restart Life Sciences) Research & Development : $0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Restart Life Sciences Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Restart Life Sciences's Research & Development for the three months ended in Dec. 2024 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was $0.00 Mil.

Restart Life Sciences Research & Development Historical Data

The historical data trend for Restart Life Sciences's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Restart Life Sciences Research & Development Chart

Restart Life Sciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Research & Development

Get a 7-Day Free Trial

0.04

0.67

0.09

0.05

Restart Life Sciences Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Research & Development	Get a 7-Day Free Trial															-	-	-	-	-

Restart Life Sciences Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Restart Life Sciences (OTCPK:NMLSF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Restart Life Sciences Research & Development Related Terms

Thank you for viewing the detailed overview of Restart Life Sciences's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Restart Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Restart Life Sciences Corp (OTCPK:NMLSF) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

HN30:Germany HEAL:Canada

Address

700-838 West Hastings St, Vancouver, BC, CAN, V6C 0A6

Website

https://www.restartlife.co

Restart Life Sciences Corp is a Canadian life sciences company dedicated to addressing today's health challenges with wellness solutions. It is focus is on creating health foods that address the needs of this community. Its Flagship developments includes Autism Spectrum, Health-Related Foods, Psilocybin Clinical Trial for Fragile X Syndrome, Orphan Drug Designation (FDA and EMA).